Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
What was recalled
Pramipexole Dihydrochoride Tablets 0.25 mg, 90-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-197-16
Recalling firm
Zydus Pharmaceuticals USA Inc
NDC code
68382-197-16
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1444-2019
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.